Xtant Medical Holdings Files Q1 2025 10-Q
Ticker: XTNT · Form: 10-Q · Filed: May 12, 2025 · CIK: 1453593
| Field | Detail |
|---|---|
| Company | Xtant Medical Holdings, Inc. (XTNT) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
XTNT Q1 2025 10-Q filed. Financials and ops details out.
AI Summary
Xtant Medical Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and business operations for the first quarter of 2025. Key financial data and operational updates are presented within this report.
Why It Matters
This filing provides investors and analysts with the latest financial health and operational status of Xtant Medical Holdings, Inc., crucial for understanding its market position and future prospects.
Risk Assessment
Risk Level: medium — 10-Q filings are standard for public companies, but the specific financial performance and disclosures within this report will determine the actual risk level for investors.
Key Numbers
- 20250331 — Report Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 20250512 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Xtant Medical Holdings, Inc. (company) — Filer of the 10-Q report
- Bacterin International Holdings, Inc. (company) — Former name of Xtant Medical Holdings, Inc.
- K KITZ INC (company) — Former name of Xtant Medical Holdings, Inc.
- 001-34951 (company) — SEC File Number for Xtant Medical Holdings, Inc.
FAQ
What were Xtant Medical Holdings' total revenues for the first quarter of 2025?
The filing does not explicitly state the total revenues for the first quarter of 2025 in the provided text snippet. Specific revenue figures would be found within the detailed financial statements of the full 10-Q document.
What is the company's net income or loss for the period ending March 31, 2025?
The provided text snippet does not contain specific net income or loss figures for the period ending March 31, 2025. These details are typically located in the Consolidated Statements of Operations within the full 10-Q.
When did Xtant Medical Holdings, Inc. change its name from Bacterin International Holdings, Inc.?
Xtant Medical Holdings, Inc. changed its name from Bacterin International Holdings, Inc. on June 15, 2010.
What is the company's primary SIC code?
The company's Standard Industrial Classification (SIC) code is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Where is Xtant Medical Holdings, Inc. headquartered?
Xtant Medical Holdings, Inc. is located at 664 Cruiser Lane, Belgrade, Montana, 59714.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Xtant Medical Holdings, Inc. (XTNT).